Mycobacterium genavense sp. nov. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Mycobacterium genavense sp. nov.

Int J Syst Bacteriol. 1993 Oct;43(4):841-3. Unique Identifier : AIDSLINE GENBANK/X60070
Bottger EC; Hirschel B; Coyle MB; Institut fur Medizinische Mikrobiologie, Medizinische Hochschule; Hannover, Germany.


Abstract: Strains of a suggested novel type of mycobacterium have been repeatedly isolated from patients with AIDS. We summarize the results of tests performed to determine enzymatic activities and metabolic properties, the results of fatty acid analyses, and the results of a comparative 16S rRNA sequence determination. We propose formally that this organism represents a new species, Mycobacterium genavense. The type strain is strain 2289, a culture of which has been deposited in the American Type Culture Collection as strain ATCC 51234.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS Cell Division Comparative Study Fatty Acids/ANALYSIS Human Molecular Sequence Data Mycobacterium/*CLASSIFICATION/ENZYMOLOGY/GROWTH & DEVELOPMENT/ *GENETICS Mycobacterium Infections/COMPLICATIONS/MICROBIOLOGY RNA, Ribosomal, 16S/*GENETICS JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/complicationscelldivisioncomparativestudyfattyacids/analysishumanmolecularsequencedatamycobacterium/KWDclassification/enzymology/growth&development/KWDgeneticsmycobacteriuminfections/complications/microbiologyrna,ribosomal,16s/KWDgeneticsjournalarticle
940330
M9430974

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .